Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 15, 2019
Total Value: $910M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SPARK THERAPEUTICS INC | 940,000 | $107M | 11.8% | $60.22 | — | COM | 84652J103 |
| — | BLUEPRINT MEDICINES CORP | 848,648 | $67.93M | 7.5% | $60.28 | — | COM | 09627Y109 |
| — | MYOKARDIA INC | 1,285,000 | $66.81M | 7.3% | $39.07 | — | COM | 62857M105 |
| — | SAGE THERAPEUTICS INC | 400,000 | $63.62M | 7.0% | $89.71 | — | COM | 78667J108 |
| — | BLUEBIRD BIO INC | 357,500 | $56.24M | 6.2% | $126.58 | — | COM | 09609G100 |
| — | INVITAE CORP | 2,200,000 | $51.52M | 5.7% | $16.73 | — | COM | 46185L103 |
| FATE | FATE THERAPEUTICS INC | 2,550,000 | $44.8M | 4.9% | $4.33 | +264.7% | COM | 31189P102 |
| — | MAGENTA THERAPEUTICS INC | 2,643,318 | $43.53M | 4.8% | $12.22 | — | COM | 55910K108 |
| BLFS | BIOLIFE SOLUTIONS INC | 2,428,571 | $43.45M | 4.8% | $15.38 | +3.4% | COM NEW | 09062W204 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 445,000 | $41.59M | 4.6% | $83.52 | +0.1% | COM | 02043Q107 |
| CDXS | CODEXIS INC | 2,025,000 | $41.57M | 4.6% | $5.90 | +229.0% | COM | 192005106 |
| — | AUDENTES THERAPEUTICS INC | 1,010,000 | $39.41M | 4.3% | $26.14 | — | COM | 05070R104 |
| SRPT | SAREPTA THERAPEUTICS INC | 305,000 | $36.35M | 4.0% | $128.37 | +0.2% | COM | 803607100 |
| — | GENMARK DIAGNOSTICS INC | 3,365,000 | $23.86M | 2.6% | $6.69 | — | COM | 372309104 |
| AGIO | AGIOS PHARMACEUTICALS INC | 335,000 | $22.59M | 2.5% | $66.22 | -12.0% | COM | 00847X104 |
| VYGR | VOYAGER THERAPEUTICS INC | 1,128,075 | $21.59M | 2.4% | $14.86 | — | COM | 92915B106 |
| — | CONSTELLATION PHARMCETICLS I | 1,556,999 | $21.1M | 2.3% | $6.31 | — | COM | 210373106 |
| ILMN | ILLUMINA INC | 60,000 | $18.64M | 2.0% | $196.93 | +48.1% | COM | 452327109 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 300,000 | $15.88M | 1.7% | $32.45 | — | COM | 37890U108 |
| — | GRITSTONE ONCOLOGY INC | 1,120,586 | $14.9M | 1.6% | $13.90 | — | COM | 39868T105 |
| EDIT | EDITAS MEDICINE INC | 480,000 | $11.74M | 1.3% | $29.14 | -22.3% | COM | 28106W103 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,080,000 | $10.3M | 1.1% | $8.03 | +27.2% | COM | 800677106 |
| — | HOMOLOGY MEDICINES INC | 350,000 | $9.706M | 1.1% | $21.76 | — | COM | 438083107 |
| ONC | BEIGENE LTD | 70,000 | $9.24M | 1.0% | $149.93 | — | SPONSORED ADR | 07725L102 |
| EVH | EVOLENT HEALTH INC | 550,000 | $6.919M | 0.8% | $17.59 | -10.0% | CL A | 30050B101 |
| CDNA | CAREDX INC | 200,000 | $6.304M | 0.7% | $11.47 | +154.1% | COM | 14167L103 |
| ALEC | ALECTOR INC | 331,039 | $6.197M | 0.7% | $18.92 | 0.0% | COM | 014442107 |
| GILD | GILEAD SCIENCES INC | 80,000 | $5.201M | 0.6% | $50.86 | 0.0% | COM | 375558103 |
| DNLI | DENALI THERAPEUTICS INC | 100,000 | $2.322M | 0.3% | $18.14 | +15.3% | COM | 24823R105 |